HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kemin, Henkel Settle Lawsuit, Counterclaims Over Lutein Representations

This article was originally published in The Tan Sheet

Executive Summary

Henkel must refrain from expressly representing its Xangold lutein ester is or contains "lutein" or "free lutein," and Kemin Foods is prohibited from describing its FloraGLO supplement as "pure lutein," according to a late July agreement resolving litigation between the two companies.

Henkel must refrain from expressly representing its Xangold lutein ester is or contains "lutein" or "free lutein," and Kemin Foods is prohibited from describing its FloraGLO supplement as "pure lutein," according to a late July agreement resolving litigation between the two companies.

Under the settlement, Henkel will adopt suggested labeling guidelines recommending its customers use a generic identifier, such as "lutein esters" or "marigold extract," other than "lutein" or "free lutein."

The agreement allows Kemin to represent its current FloraGLO product as "purified" or "concentrated."

Kemin filed suit in Des Moines, Iowa federal court in September 1998, asserting Henkel's Xangold lutein ester product attempted to unfairly compete with its patented FloraGLO product. Des Moines-based Kemin alleged Xangold was unproven because it contains lutein esters, not the pure lutein found in FloraGLO that has been proven beneficial in various antioxidant trials (1 (Also see "Henkel Xangold Lutein Competes Unfairly with Kemin FloraGLO, Firm Charges" - Pink Sheet, 14 Sep, 1998.)).

Kemin charged Henkel with misleading advertising under the Lanham Act, intentional interference with contracts and prospective business advantage and unfair competition.

In its countersuit, Henkel alleged Kemin's promotional material misrepresented that its FloraGLO lutein was pure.

Under the settlement agreement, neither company admits fault or wrongdoing. Both firms agree not to expressly represent that each other's products are adulterated or infringe patents held by the other.

Henkel agrees not to distribute, in hard copy or over the Internet, marketing pieces challenged by Kemin and will refrain from using the phrase "the most natural form of lutein" in its promotional material.

The agreement allows both companies to cite or discuss for promotional purposes scientific studies or other information regarding the health benefits of lutein or lutein esters. The settlement is effective through Dec. 31, 2002.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel